Indian Expert Dr. A. Ramkishan Appointed by WHO to Advisory Panel

HYDERABAD: Dr A. Ramkishan, deputy drugs controller of India, Central Drugs Standard Control Organization (CDSCO), has been appointed as one of the experts on the advisory panel on biological standardisation for four years by The World Health Organisation (WHO).

Dr Ramkishan who hails from Hyderabad is the first Indian doctor on the committee. He has 25 years of regulatory service in CDSCO which he joined in 1998 as a drug inspector in Mumbai.

A pharmacy graduate from Kakatiya University, Dr Ramkishan has been awarded 35 awards and honours.

Speaking to Deccan Chronicle Dr Ramkishan said, “The opportunity came on the basis of scientific capacity and expertise and experience in the field of pharmaceutical sciences as well as publications and regulatory experience. For the first time a regulator has been chosen on the panel and this is a huge opportunity for me.”

Related Posts

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Food regulator FSSAI on Friday said it has suspended the licence of Punjab-based Rehaan Healthcare after it found serious violations of rules at the company’s health supplements and nutraceuticals manufacturing…

Pharma companies in a flux over Trump’s 200% tariff move on generics

India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty